Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.

J Glob Oncol · 2018 · PMC6223523 · PMID 30084749

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

Although the beneficial effect of metformin was seen in patients regardless of CRC stage, metformin’s effect on median OS and PFS was statistically significant (OS) or close to significance (PFS) only in patients with stage III CRC.

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.